Steward Partners Investment Advisory’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.38K Hold
600
﹤0.01% 3454
2025
Q1
$4.5K Buy
+600
New +$4.5K ﹤0.01% 3407
2022
Q1
Sell
-150
Closed -$2K 3283
2021
Q4
$2K Buy
+150
New +$2K ﹤0.01% 3002
2021
Q2
Sell
-1,000
Closed -$10.2K 7103
2021
Q1
$10.2K Buy
+1,000
New +$10.2K ﹤0.01% 2777